Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

The Journal of Gynecologic Oncology and the Asian Society of Gynecologic Oncology: the history, the present and the future

Chang KH, Kim JW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium

Yoo HJ, Park SY, Lim MC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
9th Korea-Japan Gynecologic Cancer Joint Meeting

Ryu HS, Sugiyama T

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer

Munoz M, Ramirez PT, Echeverri , Alvarez LG, Palomino M, Pareja LR

OBJECTIVE: To report the clinical presentation and oncologic outcomes of a series of patients who presented with an abdominal or pelvic mass and were diagnosed with a gastrointestinal stromal tumor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer

Abaid LN, Rettenmaier MA, Brown JV, Micha JP, Mendivil A, Wabe MA, Goldstein

OBJECTIVE: The purpose of this retrospective study was to assess the tolerability and efficacy of sequential chemotherapy and radiotherapy for the treatment of high risk endometrial cancer. METHODS: We conducted a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Major clinical research advances in gynecologic cancer in 2011

Suh DH, Kim K, Kim JW

The annual review of 2011 comprised 11 themes of major research achievements in gynecologic oncology including breast cancer. A potential paradigm shift in the management of ovarian cancer was reviewed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Complete biologic response to taxane based chemotherapy confirmed by [18F]FDG PET/CT and surgery in a cancer of unknown primary site

Hwang JE, Yoon JY, Bae WK, Shim HJ, Chung IJ

Cancers of an unknown primary site are heterogenous with respect to their clinical and pathologic features. They are generally very aggressive, but specific favorable subsets have a better prognosis. For...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Late presentation of metastatic smooth muscle neoplasm of the uterus with low malignant potential

Canciani G, Burbos N, Duncan TJ, Lonsdale R, Nieto JJ

A 48-year-old woman underwent total abdominal hysterectomy with conservation of the ovaries and tubes. Histology showed a well-circumscribed smooth muscle tumor with foci of degeneration (including infarct-type necrosis) but no...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009

Lee YH, Choi KS, Lee HY, Jun JK

OBJECTIVE: The National Cancer Screening Program (NCSP) began in 1999. In this report, we evaluate the results of the NCSP for cervical cancer in 2009 and provide participation rates in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics of thyroid incidentalomas detected by pre-treatment [18F]FDG PET or PET/CT in patients with cervical cancer

Lee WM, Kim BJ, Kim MH, Choi SC, Ryu SY, Lim I, Kim K

OBJECTIVE: Considering the increased use of [18F]FDG PET or PET/CT, the clinical significance of thyroid incidentalomas is the subject of controversy. The aim of this study was to determine the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media

Min KJ, So KA, Lee J, Hong HR, Hong JH, Lee JK, Kim AR

OBJECTIVE: To validate the efficacy of Seeplex HPV4A ACE for the detection of high-risk (HR) human papillomavirus (HPV) and HPV 16 and/or HPV 18 genotypes as compared to the PCR...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Bansal N, Marchion D, Bicaku E, Xiong Y, Chen N, Stickles X, Sawah EA, Wenham RM, Apte SM, Gonzalez-Bosquet J, Judson PL, Hakam A, Lancaster

OBJECTIVE: The BCL2 family proteins are critical mediators of cellular apoptosis and, as such, have been implicated as determinants of cancer cell chemo-sensitivity. Recently, it has been demonstrated that the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Minichromosome maintenance 7 protein is a reliable biological marker for human cervical progressive disease

Lobato S, Tafuri A, Fernandes , Caliari MV, Silva MX, Xavier MA, Vago AR

OBJECTIVE: This study focused on comparing the expression levels of p16, Ki-67, and minichromosome maintenance 7 (MCM7) protein in normal and affected cervical epithelium to ascertain the biological significance of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer

Chung HH, Kwon HW, Kang KW, Kim JW, Park NH, Song YS, Kang SB

OBJECTIVE: To determine whether [18F]FDG uptake on PET/CT imaging before surgical staging has prognostic significance in patients with epithelial ovarian cancer (EOC). METHODS: Patients with EOC were imaged with integrated PET/CT...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr